Henrietta Fore Net Worth & Insider Trades
Henrietta Fore - Director, Theravance Biopharma, Inc
What is Henrietta Fore's Net Worth?
The current estimated net worth of Theravance Biopharma, Inc's Director, Henrietta Fore, is estimated to be about $6.09M . Henrietta Fore owns about 24,000 units of Theravance Biopharma, Inc common stock. In the last 3 years at Theravance Biopharma, Inc, Henrietta Fore has sold an estimated value of $0 worth.
What is Henrietta Fore's Past Insider Trading?
Henrietta Fore's largest purchase order was 6,000 units , worth over $143.93K on August 11, 2017. In total, Henrietta Fore has made about 5 transactions over 3 years of their time at Theravance Biopharma, Inc. Henrietta Fore usually trades in May, with the busiest year in 2017.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Henrietta Fore
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Henrietta Fore's' Mailing Address?
- Mailing address is Theravance, Inc. 901 Gateway Blvd. South San Francisco CA 94080 CA
Theravance Biopharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Rick E Winningham | 2020 | $1,014,455 | - | $579,646 | - | $579,646 | $6,045 | $6,577,746 |
Rick E Winningham | 2019 | $983,710 | - | $473,906 | - | $473,906 | $5,496 | $5,932,411 |
Rick E Winningham | 2018 | $956,600 | $74,767 | $690,154 | - | $690,154 | $5,000 | $2,522,841 |
Andrew A. Hindman | 2020 | $551,608 | - | $265,278 | - | $265,278 | $5,920 | $2,097,950 |
Andrew A. Hindman | 2019 | $315,000 | $175,000 | $216,000 | $2,204,956 | $216,000 | - | $3,757,956 |
Brett Haumann | 2020 | $572,569 | - | $213,589 | - | $213,589 | $53,267 | $2,742,625 |
Brett Haumann | 2019 | $543,047 | - | $170,000 | - | $170,000 | $42,382 | $2,464,280 |
Brett Haumann | 2018 | $497,810 | $34,125 | $315,000 | - | $315,000 | $414,300 | $1,517,194 |
Vijay Sabesan | 2020 | $407,677 | - | $760,326 | - | $760,326 | $6,541 | $3,077,744 |
Bradford J. Shafer | 2020 | $556,321 | - | $264,999 | - | $264,999 | $6,045 | $2,730,565 |
Bradford J. Shafer | 2019 | $537,403 | - | $215,611 | - | $215,611 | $6,983 | $2,468,848 |
Bradford J. Shafer | 2018 | $518,080 | $33,770 | $311,726 | - | $311,726 | $5,000 | $1,124,537 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm
What are Theravance Biopharma, Inc's Past Insider Trades?
Theravance Biopharma, Inc's most recent insider trade came on November 22, 2023 by Rhonda Farnum who sold 9,360 units worth $96.95K . In the last 8 years, insiders at Theravance Biopharma, Inc have sold an estimated value of $152.42M and bought an estimated value of $26.3M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Bradford Shafer, EVP, Rick Winningham, CHIEF EXECUTIVE OFFICER, and Richard Graham, SVP .
Theravance Biopharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |